INTRODUCTIONRecurrent aphthous stomatitis (RAS) is the most common oral lesion; it has unknown etiology and is characterized by periodic oval, shallow, painful ulcers, gray or yellowish in color, which are…
Read More
INTRODUCTIONAn estimated 15-25% of the population has previously experienced urticaria, with the highest prevalence in women and the middle-aged population.1 Chronic urticaria (CU) is defined as wheals, angioedema, or both,…
Read More
INTRODUCTIONPsoriasis is a chronic immune-mediated inflammatory disease affecting the skin. First-line treatment for mild-to-moderate psoriasis is topical treatment, including corticosteroids, vitamin D analogs, keratinolytics, calcineurin inhibitors, salicylic acid, and tar.1,2…
Read More
INTRODUCTIONBrodalumab is an interleukin-17 receptor A antagonist indicated for the systemic treatment of moderate-to-severe plaque psoriasis in adult patients who have lost response or failed to respond to other systemic…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease of the apocrine gland-bearing areas such as the axilla, groin, and perianal skin, which is characterized by deep seated painful nodules,…
Read More
INTRODUCTIONSemaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with…
Read More
INTRODUCTIONDiscoid lupus erythematosus (DLE) is a chronic inflammatory skin disease that occurs with or without systemic lupus erythematosus (SLE). DLE treatment is challenging, and there is paucity of effective therapeutic…
Read More
INTRODUCTIONAlopecia areata (AA) is a form of non-scarring alopecia that results from an autoimmune process that targets hair follicles.1 The severity of the disease varies from a focal, patchy hair…
Read More
COMMENTARYThe most recently suggested curricular guidelines presented by the Pediatric Dermatology Research Alliance Special Interest Group in Pediatric Skin of Color (PSOCG) listed pityriasis alba (PA) as the second most…
Read More
INTRODUCTIONAcne vulgaris, the eighth most prevalent disease globally,1,2 is a multifactorial skin condition characterized by the excess production of sebum, epithelial follicle hyperkeratinization, and inflammation.1-3 Clinical manifestations of acne can…
Read More
INTRODUCTIONWhen considering treatment strategies and formulations that can target hyperpigmentation, two major challenges exist. Firstly, the causes, triggers, and pathways involved are multifaceted and plentiful. Not all pigmentary conditions are…
Read More
INTRODUCTIONTopical treatments are often used both as first-line monotherapy for mild plaque psoriasis and as adjunct therapy for patients with more severe disease.1-3 Psoriasis is a chronic condition, and patients…
Read More
